Literature DB >> 22327951

Update on the management of simple febrile seizures: emphasis on minimal intervention.

Titilayo Oluwabusi1, Sunil K Sood.   

Abstract

PURPOSE OF REVIEW: We summarize recent clinical reviews and updated American Academy of Pediatrics (AAP) clinical guidelines for the management of children with simple febrile seizures. RECENT
FINDINGS: There has been a dramatic reduction in the incidence of bacterial meningitis and of occult bacteremia since the advent of Haemophilus influenzae type b and Streptococcus pneumoniae immunization. This has made routine laboratory evaluation for these bacterial infections unnecessary in a fully immunized, well appearing child who presents with a simple febrile seizure. At the same time there is increasing evidence that the neurotropic human herpes viruses 6 and 7 (HHV-6, HHV-7) comprise a significant proportion of viral infections associated with febrile seizures, and may be the primary cause of the seizure in many instances. Recent evidence-based guidelines emphasize the lack of a need for routine laboratory and neurodiagnostic evaluation, and for prophylactic antipyretics and anticonvulsants, in the majority of children with simple febrile seizures.
SUMMARY: If a child who is fully immunized according to the recommended schedule presents with a simple febrile seizure, minimal intervention should be the norm. Routine blood tests and routine lumbar punctures are usually unnecessary, and the risks of neurodiagnostic procedures (imaging or EEG), prophylactic antipyretics and anticonvulsants far outweigh their potential benefits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327951     DOI: 10.1097/MOP.0b013e3283506765

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  14 in total

1.  Rational approach to management of febrile seizures.

Authors:  Siba Prosad Paul; Ravindranath Chinthapalli
Journal:  Indian J Pediatr       Date:  2012-07-06       Impact factor: 1.967

2.  Intermittent oral levetiracetam reduced recurrence of febrile seizure accompanied with epileptiform discharge: a pilot study.

Authors:  Lin-Yan Hu; Xiu-Yu Shi; Hui Li; Meng-Na Zhang; Shu-Fang Ma; Li-Ping Zou
Journal:  Ital J Pediatr       Date:  2018-06-15       Impact factor: 2.638

Review 3.  Actual insights into the clinical management of febrile seizures.

Authors:  Mario Mastrangelo; Fabio Midulla; Corrado Moretti
Journal:  Eur J Pediatr       Date:  2014-01-30       Impact factor: 3.183

4.  PREVALENCE OF BACTERAEMIA AMONGST CHILDREN WITH FEBRILE SEIZURES AT THE UNIVERSITY COLLEGE HOSPITAL, IBADAN.

Authors:  O O Jarrett; O J Fatunde; K Osinusi; I A Lagunju
Journal:  Ann Ib Postgrad Med       Date:  2018-12

Review 5.  Febrile seizures.

Authors:  Sajun Chung
Journal:  Korean J Pediatr       Date:  2014-09-30

6.  Febrile seizure recurrence reduced by intermittent oral levetiracetam.

Authors:  Lin-Yan Hu; Li-Ping Zou; Jian-Min Zhong; Lei Gao; Jian-Bo Zhao; Nong Xiao; Hong Zhou; Meng Zhao; Xiu-Yu Shi; Yu-Jie Liu; Jun Ju; Wei-Na Zhang; Xiao-Fan Yang; Patrick Kwan
Journal:  Ann Clin Transl Neurol       Date:  2014-02-24       Impact factor: 4.511

7.  Sydenham chorea in a 5-year-old Saudi patient.

Authors:  Amer A Lardhi
Journal:  Neurosciences (Riyadh)       Date:  2015-01       Impact factor: 0.906

Review 8.  Management of Pediatric Febrile Seizures.

Authors:  Daniela Laino; Elisabetta Mencaroni; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2018-10-12       Impact factor: 3.390

9.  Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra™) Compared to Separate MMR + V Vaccination.

Authors:  Vincent Bauchau; Lionel Van Holle; Carine Cohen
Journal:  Drug Saf       Date:  2015-11       Impact factor: 5.606

10.  Clinical characteristics and electroencephalogram analysis of levetiracetam in the treatment of children with febrile seizure recurrence.

Authors:  Xue-Chao Li; Ling-Ling Lu; Jian-Zhong Wang; Miao Wang; Yu Gao; Ye-Xin Lin; Zhong-Hou Han
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.